Genfit.fr

Categories: New newsletter subcribe

130Newsletters

0Subscriptions

Click here to subscribe to Genfit.fr

Newsletters

GENFIT présente ses résultats fin anciers et l’avancée de son portefeuille de programmes de R&D au pr emier semestre 2019 Genfit.fr
5 years ago
GENFIT renforce son équipe dirigeante aux États-Unis Genfit.fr
5 years ago
GENFIT Reinforces Corporate Leadership in the U.S. Genfit.fr
5 years ago
📃 [2019.09.09] GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer Genfit.fr
5 years ago
📃 [2019.09] GENFIT: Board of Directors, Represented by Chai rman Jean-François Mouney, App oints Pascal Prigent as New CEO Genfit.fr
5 years ago
📃 [2019.07.29] FDA and EMA G rant GENFIT’s Elafibranor Orp han Drug Designation for Primary Biliary Cholangitis (PBC) Genfit.fr
5 years ago
📃 [2019.06.24] GENFIT and Terns Pha rmaceuticals Announce $228MM Strateg ic Partnership to Develop and Commer cialize Elafibranor in Greater China Genfit.fr
6 years ago
📃 [2019.06.12] GENFIT Announces Active Partici pation in the 2nd Annual International NASH Day Genfit.fr
6 years ago
📃 [2019.05.23] GENFIT Launches a Combi nation Therapy Clinical Program in NASH Genfit.fr
6 years ago
📃 [2019.05.14] GENFIT: Positive 36-month DSMB Recommendation fo r Continuation of Phase 3 RESOLV E-IT Study of Elafibranor in NASH Genfit.fr
6 years ago
📃 [2019.05.10] ERRATUM - GENFIT: Ordinary Sh areholder’s Meeting of THURSDAY June 13, 2019 Genfit.fr
6 years ago
📃 [2019.05.10] GENFIT: Ordinary Sh areholder’s Meeting of June 13, 2019 Genfit.fr
6 years ago
📃 [2019.04.30] GENFIT: First qu arter 2019 financial information Genfit.fr
6 years ago
📃 [2019.04.18] GENFIT: FDA Grant of Breakthrough Ther apy Designation to Elafibranor for the Treatment of PBC Genfit.fr
6 years ago
📃 [2019.04.13] GENFIT: Addition al Positive Data from the Phase 2 Clinical Trial Evaluating Elaf ibranor in PBC at the ILC™ 2019 Genfit.fr
6 years ago
📃 [2019.04.04] GENFIT: Upcoming Presentations o n NASH, PBC and Diagnostics at the EASL ILC 2019 Genfit.fr
6 years ago
📃 [2019.03.29] GENFIT: announ ces Closing of Global Offering Genfit.fr
6 years ago
📃 [2019.03.27] GENFIT:GENFIT Announces Pricing of Global O ffering and Approval to List on Nasdaq Global Select Market Genfit.fr
6 years ago
📃 [2019.03.14] GENFIT: Launch of Pro posed Global Offering & Nasdaq listing Genfit.fr
6 years ago
📃 [2019.03.11] GENFIT: FDA Protocol Clearance for Ph ase 2 Clinical Trial of Elafibranor in Pediatric NASH Genfit.fr
6 years ago

© 2025